Veld Pharmaceuticals GmbH

Business news, market intelligence, and global industry analysis.

The Latest

Representative image of a large-scale copper mining operation in Chile, reflecting investor focus on Antofagasta PLC shares, Q1 2026 production stability, and the Centinela Second Concentrator growth story.

Antofagasta (LSE: ANTO) surges 5% as Q1 output beats consensus and Centinela build holds schedule

Shubman Gill’s 86 steers Gujarat Titans past Kolkata Knight Riders in IPL 2026

Kizik debuts Freedom Run, betting step-in technology can break into performance running

Kizik launches Freedom Run as it pushes hands-free footwear into the performance running market

Representative image of industrial equipment and specialty vehicles, illustrating the Terex Corporation (NYSE: TEX) stock story as investors watch whether the post-merger machinery giant can keep climbing into May 1 earnings.

Can Terex Corporation (NYSE: TEX) keep climbing into May 1 earnings?

How rare disease medicine access in Africa is moving from ad hoc supply to structured compliance-led programs

How Veld Pharmaceuticals and Chiesi are reshaping rare disease drug access in Africa through compliance-led programs. Read what this means for the sector.

μFR system
αvβ6-integrin
α4β7 integrin
ZYUS Life Sciences
Zyrtec
Zyprexa Zydis
Zynga
Zynext Ventures USA LLC
Zynext Ventures
Zynex

April 15, 2026